9:30AM Exploring Novel Approaches to Mitigate Gene Therapy Immunogenicity
Time: 9:30 am
day: Conference Day 2
Details:
• What are the latest advances in immunosuppression protocols to mitigate immune responses to the AAV vector and the transgene product?
• Discuss the risks and benefits of these strategies, including patient safety considerations and immune system recovery
• Sharing examples demonstrating success or challenges with immunosuppressive treatments
